Abstract Body

Background:

Canada and the United States continue to face increases in both fatal and non-fatal overdoses. In Canada, the magnitude of the overdose crisis is most severe in British Columbia (BC), with sex disparities among people experiencing fatal overdoses higher than in any other province. However, little is known about sex disparities pertaining to non-fatal overdoses (NFODs) among people living with HIV (PLWH).

Methods:

We used data from the Comparative Outcomes and Service Utilization Trends (COAST) study, a population-based longitudinal cohort study in BC, Canada. Administrative health records are available for all known PLWH and a 10% random sample of the HIV-negative population, all ≥19 years of age. Using data from January 1st, 2012 – March 31st, 2020, we identified 12,717 PLWH and 473,947 people living without HIV. We defined NFODs using ICD-9/10-CA codes in linked administrative data sets (i.e., hospital admissions, emergency department, and physician visits).

Results:

Within COAST, 21.8% (n=2767) of PLWH and 49.7% (n=235,655) of the HIV-negative group are female. Among females living with HIV (FLWH), 18.3% (n=508) experienced at least one NFOD, compared to 10.7% (n=1069) of males living with HIV, 1.3% (n=3043) of females and 1.5% (n=3473) of males living without HIV. FLWH who experienced an initial NFOD had, on average, 2.5 recurrent NFODs; males living with HIV had, on average, 1.8. In contrast, males and females in the HIV-negative comparison group had < 1 recurrent NFOD. Overall, FLWH had the highest NFOD incidence (10.53/100 person-years (PY); 95%CI: 10.05, 11.03). These rates surpassed those of males living with HIV (4.86/100 PY; 95% CI: 4.69, 5.04), and females (0.37/100 PY; 95%CI: 0.36, 0.38) and males (0.44/1000 PY; 95%CI: 0.43, 0.45) living without HIV. In unadjusted analyses, FLWH were more likely to experience an NFOD than men living with HIV (incidence rate ratio (IRR): 2.17, 95%CI: 2.04, 2.30), whereas females living without HIV were less likely to experience an NFOD (IRR: 0.83; 95%CI: 0.80, 0.86) in comparison to males living without HIV.

Conclusions:

Our analyses demonstrate that among PLWH, females experience a higher incidence of NFOD events. This sex disparity is important to explore further, given the potential for adverse health outcomes after NFODs. These findings have implications by suggesting the need for policies and programs oriented toward women to mitigate overdoses, especially those living with HIV.